After being asked in December 2021 to weigh in on whether the U.S. Supreme Court should take up Monsanto’s petition to review a $25 million Roundup cancer verdict, the U.S. Department of Justice (DOJ) has recommended that the lower court verdict be allowed to stand, potentially dashing Monsanto’s owner Bayer…

Johnson & Johnson has failed to convince a judge that a lawsuit alleging that the company exposed its workers to asbestos should be dismissed. In the midst of battling tens of thousands of talcum powder lawsuits, on April 12, J&J appealed to U.S. Bankruptcy Judge Michael Kaplan to dismiss a…

Opening arguments began on May 4th for the first Roundup weedkiller cancer trial outside of California. The trial, which is being held in Kansas City, Missouri, is also distinguished as the first trial in which Hugh Grant, the former CEO of Monsanto who ran the company for 15 years, will…

The U.S. Food and Drug Administration (FDA) has released a safety warning to patients and health care providers regarding genetic non-invasive prenatal screening (NIPS) tests. These tests have been found to give false results that have resulted in misinformed decisions about the health of the pregnant person and the fetus. …

A lawsuit filed in late April against Cerebral, an online mental health startup, has led to a decision by the company to stop prescribing Adderall and Ritalin to new patients as of May 9. The lawsuit was filed by Cerebral former vice president of product and engineering, Matthew Truebe. In…

In July 2021, Washington state’s Attorney General (AG), Bob Ferguson, rejected a national opioid settlement with Johnson & Johnson and three of the largest drug distributors, AmerisourceBergen, Cardinal Health, and McKesson. On May 3, AG Ferguson announced that the settlement he secured has resulted in over $40 million more than…

Florida Attorney General, Ashley Moody, announced that the state has reached a settlement agreement with Walgreens Co. over the drug-store chain’s alleged role in contributing to the opioid epidemic. The $683 million agreement was announced May 5, nearly one month into a jury trial that began April 11 in Pasco…

The U.S. Food and Drug Administration (FDA) announced marketing approval for the first diagnostic test for amyloid plaque, a key marker used to detect Alzheimer’s disease. The Lumipulse G β-Amyloid Ratio (1–42/1–40) test will be used on older adults to help confirm the presence of the progressive disease that’s also…

A jury in a Florida federal court found that defective military earplugs sold by 3M and its subsidiary, Aearo Technologies, were responsible for a U.S. Army veteran’s hearing damage and awarded the former soldier $2.2 million, Bloomberg Law reported. The verdict for Jonathon Vaughn, reached April 29 in Gainesville and…